PedAM
Pediatric Disease Annotations & Medicines
| Disease | sickle cell anemia |
| Symptom | C0030193|pain |
| Sentences | 39 |
| PubMedID- 20464044 | Patients with acute pain episode associated with sickle cell disease, headache, backache, renal colic, and trauma (specific isolated injuries) were included. |
| PubMedID- 25047658 | Sleep disturbance, depression and pain in adults with sickle cell disease. |
| PubMedID- 25842346 | This analysis examined the influence of quantifiable parameters of daily sleep continuity, primarily sleep duration and sleep fragmentation, on daily pain in adults with sickle cell disease. |
| PubMedID- 24769786 | Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care. |
| PubMedID- 25916256 | Satisfied or not satisfied: pain experiences of patients with sickle cell disease. |
| PubMedID- 23799317 | The differential diagnosis of chest pain in a patient with sickle cell disease is difficult and may encompass several serious conditions, including chest syndrome, pulmonary embolism and infectious complications. |
| PubMedID- 21708890 | Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. |
| PubMedID- 21910605 | We suggest there are clear differences between the reports of pain in patients with sickle cell disease taking short-acting narcotics for pain management as compared to those who are not, a pattern that does not distinguish patients who are managed with long-acting preparations. |
| PubMedID- 21778705 | Lactate dehydrogenase and severity of pain in children with sickle cell disease. |
| PubMedID- 24315252 | Chronic pain in adults with sickle cell disease (scd) is a complex multidimensional experience that includes biologic, psychologic, sociologic, and spiritual factors. |
| PubMedID- 20466223 | We compared meperidine and tramadol with respect to their effects on the hemodynamics and pain relief in patients with sickle cell disease who were admitted to the emergency department with painful crisis. |
| PubMedID- 24211787 | Recent evidence of neuropathic pain among adults with sickle cell disease (scd) reveals a need for adjuvant analgesic treatments for these patients. |
| PubMedID- 24889181 | Nonsteroidal anti-inflammatory drugs (nsaids) used to treat pain in patients with sickle cell disease (scd) are metabolized by the cyp2c9 enzyme. |
| PubMedID- 22200862 | Background: avascular necrosis (avn) is a common morbidity in children with sickle cell disease (scd) that leads to pain and joint immobility. |
| PubMedID- 23055784 | sickle cell disease can be associated with frequent, debilitating pain crises requiring hospitalization, and patients may become emotionally dependent on their pediatric provider. |
| PubMedID- 25472968 | The ash 2014 choosing wisely((r)) recommendations include: (1) do not anticoagulate for more than 3 months in patients experiencing a first venous thromboembolic event in the setting of major, transient risk factors for venous thromboembolism; (2) do not routinely transfuse for chronic anemia or uncomplicated pain crises in patients with sickle cell disease; (3) do not perform baseline or surveillance computed tomography scans in patients with asymptomatic, early-stage chronic lymphocytic leukemia; (4) do not test or treat for heparin-induced thrombocytopenia if the clinical pretest probability of heparin-induced thrombocytopenia is low; and (5) do not treat patients with immune thrombocytopenia unless they are bleeding or have very low platelet counts. |
| PubMedID- 24167104 | Neuropathic pain in patients with sickle cell disease. |
| PubMedID- 22171826 | The clinical management of severe pain associated with sickle cell disease (scd) remains challenging. |
| PubMedID- 22737578 | 4 dactylitis, often referred to as hand-foot syndrome, is frequently the 1st manifestation of pain in children with sickle cell anemia, occurring in 50% of children by 2 years of age. |
| PubMedID- 22518081 | The peak of pain due to sickle cell disease is achieved by cold period, that of asthma, in the final phase of nocturnal rest and that of hypertension reaches its maximum at the end of the night resting phase. |
| PubMedID- 26291276 | Perspective: altered connectivity patterns associated with high pain experience in patients with sickle cell disease suggest a possible role of central mechanisms in sickle cell pain. |
| PubMedID- 21661104 | Frequently asked questions by hospitalists managing pain in adults with sickle cell disease. |
| PubMedID- 24247814 | Abdominal pain in children with sickle cell disease. |
| PubMedID- 20656451 | A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease. |
| PubMedID- 21490765 | Research is needed to determine if there is an association between acetaminophen use in early life for the management of pain in children with sickle cell disease and the increased prevalence of asthma or airway hyperreactivity. |
| PubMedID- 21527519 | Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated trv and low exercise capacity. |
| PubMedID- 20854646 | Morphine is commonly used to control moderate and severe pain associated with sickle cell disease. |
| PubMedID- 22287873 | One serious adverse event, hospitalization for vaso-occlusive pain, occurred in a patient with sickle cell disease, also thought to be unrelated to the drug. |
| PubMedID- 25161492 | We therefore sought to describe the different presentationsand patterns of abdominal pain in persons with sickle cell disease. |
| PubMedID- 23151972 | Mental health disorders influence admission rates for pain in children with sickle cell disease. |
| PubMedID- 26412995 | Hydroxyurea and zileuton differentially modulate cell proliferation and interleukin-2 secretion by murine spleen cells: possible implication on the immune function and risk of pain crisis in patients with sickle cell disease. |
| PubMedID- 25696917 | The ash 2014 choosing wisely(r) recommendations include: (1) do not anticoagulate for more than 3 months in patients experiencing a first venous thromboembolic event in the setting of major, transient risk factors for venous thromboembolism; (2) do not routinely transfuse for chronic anemia or uncomplicated pain crises in patients with sickle cell disease; (3) do not perform baseline or surveillance computed tomography scans in patients with asymptomatic, early-stage chronic lymphocytic leukemia; (4) do not test or treat for heparin-induced thrombocytopenia if the clinical pretest probability of heparin-induced thrombocytopenia is low; and (5) do not treat patients with immune thrombocytopenia unless they are bleeding or have very low platelet counts. |
| PubMedID- 21157894 | Introduction: pain in children with sickle cell disease (scd) is the leading cause of acute care visits and hospitalizations. |
| PubMedID- 24574587 | The therapeutic role of vitamin d in chronic pain associated with sickle cell disease (scd) is well-established. |
| PubMedID- 22696351 | Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. |
| PubMedID- 25764071 | Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. |
| PubMedID- 25439119 | Perceived injustice predicts stress and pain in adults with sickle cell disease. |
| PubMedID- 21775406 | Breathlessness and chest pain in a patient with sickle cell disease. |
| PubMedID- 23776145 | Clinically meaningful measurement of pain in children with sickle cell disease. |
Page: 1